Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86

Annals of the New York Academy of Sciences

Volumn 815, Issue , 1997, Pages 392-400

  Lane, Peter ^a,b  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CELL CLONE; CELL INTERACTION; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0030762536     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb52090.x     Document Type: Conference Paper

References (40)

1. LINSLEY, P. S. & J. A. LEDBETTER. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11: 191-212.
2. FREEMAN, G. J., J. G. GRIEBEN, V. A. BOUSSIOTIS, J. W. NG, V. A. RESTIVO, L. A. LOMBARD, G. S. GRAY & L. M. NADLER. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that co-stimulates human T cell proliferation. Science 262: 909-911.
3. MCLELLAN, A. D., G. C. STARLING, L. A. WILLIAMS, B. D. HOCK & D. N. HART. 1995. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule. Eur. J. Immunol. 25: 2064-2068.
4. LENSCHOW, D. J., G. H. Su, L. A. ZUCKERMAN, N. NABAVI, C. L. JELLIS, G. S. GRAY, J. MILLER & J. A. BLUESTONE. 1993. Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl. Acad. Sci. U.S.A. 90: 11054-11058.
5. PRABHU DAS, M. R., S. S. ZAMVIL, F. BORRIELLO, H. L. WEINER, A. H. SHARPE & V. K. KUCHROO. 1995. Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation. Eur. J. Immunol. 25: 207-211.
6. LINSLEY, P. S., J. L. GREENE, W. BRADY, J. BAJORATH, J. A. LEDBETTER & R. PEACH. 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1: 793-801.
7. SHAHINIAN, A., K. PFEFFER, K. P. LEE, T. M. KUNDIG, K. KISHIHARA, A. WAKEHAM, K. KAWAI, P. S. OHASHI, C. B. THOMPSON & T. W. MAK. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261: 609-612.
8. GREEN, J. M., P. J. NOEL, A. I. SPERLING, T. L. WALUNAS, G. S. GRAY, J. A. BLUESTONE & C. B. THOMPSON. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1: 501-508.
9. SCHWARTZ, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065-1068.
10. RONCHESE, F., B. HAUSMANN, S. HUBELE & P. LANE. 1994. Normal Tcell priming to a protein antigen in mice transgenic for soluble CTLA-4. J. Exp. Med. 179: 809-817.
11. LANE, P., W. GERHARD, S. HUBELE, A. LANZAVECCHIA & F. MCCONNELL. 1993. Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human γ1. Immunology 80: 56-61.
12. TOWNSEND, S. E. & J. P. ALLISON. 1993. Tumor rejection after direct Costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259: 368-370.
13. HARDING, F. A. & J. P. ALLISON. 1993. CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177: 1791-1796.
14. LANE, P., C. BURDET, S. HUBELE, D. SCHEIDEGGER, U. MÜLLER, F. MCCONNELL & M. KOSCO-VILLBOIS. 1994. B cell function in mice transgenic for mCTLA4-H gamma-1 : lack of germinal centers correlated with poor affinity maturation and class switching despite normal priming of CD4+ T cells. J. Exp. Med. 179: 819-830.
15. LINSLEY, P. S., P. M. WALLACE, J. JOHNSON, M. G. GIBSON, J. L. GREENE, J. A. LEDBETTER, C. SlNGH & M. A. TEPPER. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257: 792-795.
16. XU, J., T. M. FOY, J. D. LAMAN, T. J. WALDSCHMIDT, J. ELSEMORE, R. J. NOELLE & R. A. FLAVELL. 1994. Mice deficient for the CD40 ligand. Immunity 1: 423-431.
17. KAWABE, T., T. NAKA, K. YOSHIDA, S. SUEMATSU, N. YOSHIDA, T. KISHIMOTO & H. KIKUTANI. 1994. The immune response in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1: 167-178.
18. DE BOER, M., A. KASRAN, J. KWEKKEBOOM, H. WALTER, P. VANDENBERGHE & J. L. CEUPPENS. 1993. Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion, and efficient help for antibody production by B cells. Eur. J. Immunol. 23: 3120-3125.
19. KLAUS, S. J., L. M. PINCHUK, H. D. OCHS, C. L. LAW, W. C. FANSLOW, R. J. ARMITAGE & E. A. CLARK. 1994. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J. Immunol. 152: 5643-5652.
20. RANHEIM, E. A. & T. J. KIPPS. 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177: 925-935.
21. CORRY, D. B., S. L. REINER, P. S. LINSLEY & R. M. LOCKSLEY. 1994. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 153: 4142-4148.
22. FINCK, B. K., P. S. LINSLEY & D. WOFSY. 1994. Treatment of murine lupus with CTLA4-Ig. Science 265: 1225-1227.
23. LENSCHOW, D. J., Y. ZENG, J. R. THISTLETHWAITE, A. MONTAG, W. BRADY, M. G. GIBSON, P. S. LINSLEY & J. A. BLUESTONE. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4-Ig. Science 257: 789-792.
24. TURKA, L. A., P. S. LINSLEY, H. LIN, W. BRADY, J. M. LEIDEN, R. Q. WEI, M. G. GIBSON, X. G. ZHENG, S. MYRDAL, D. GORDON et al. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. U.S.A. 89: 11102-11105.
25. PEARSON, T. C., D. Z. ALEXANDER, K. J. WINN, P. S. LINSLEY, R. P. LOWRY & C. P. LARSEN. 1994. Transplantation tolerance induced by CTLA4-Ig. Transplantation 57: 1701-1706.
26. WALLACE, P. M., J. S. JOHNSON, J. F. MACMASTER, K. A. KENNEDY, P. GLADSTONE & P. S. LINSLEY. 1994. CTLA4-Ig treatment ameliorates the lethality of murine graft-versus-host disease across major histocompatibility complex barriers. Transplantation 58: 602-610.
27. SAYEGH, M. H., E. AKALIN, W. W. HANCOCK, M. E. RUSSELL, C. B. CARPENTER, P. S. LINSLEY & L. A. TURKA. 1995. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines, but spares Th2. J. Exp. Med. 181: 1869-1874.
28. SETHNA, M. P., L. VAN PARUS, A. H. SHARPE, A. K. ABBAS & G. J. FREEMAN. 1994. A negative regulatory function of B7 revealed in B7-1 transgenic mice. Immunity 1: 415-421.
29. KUCHROO, V. K., M. P. DAS, J. A. BROWN, A. M. RANGER, S. S. ZAMVIL, R. A. SOBEL, H. L. WEINER, N. NABAVI & L. H. GLIMCHER. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707-718.
30. FREEMAN, G. J., V. A. BOUSSIOTIS, A. ANUMANTHAN, G. M. BERNSTEIN, X. Y. KE, P. D. RENNERT, G. S. GRAY, J. G. GRIBBEN & L. M. NADLER. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2: 523-532.
31. NAKAJIMA, A., M. AZUMA, S. KODERA, S. NURIYA, A. TERASHI, M. ABE, S. HIROSE, T. SHIRAI, H. YAGITA & K. OKUMURA. 1995. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur. J. Immunol. 25: 3060-3069.
32. RACKE, M. K., D. E. SCOTT, L. QUIGLEY, G. S. GRAY, R. ABE, C. H. JUNE & P. J. PERRIN. 1995. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 96: 2195-2203.
33. WATERHOUSE, P., J. PENNINGER, E. TIMMS, A. WAKEHAM, A. SHAHINIAN, K. P. LEE, C. B. THOMPSON, H. GRIESSER & T. W. MAK. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270: 985-988.
34. TIVOL, E. A., F. BORRIELLO, A. N. SCHWEITZER, W. P. LYNCH, J. A. BLUESTONE & A. H. SHARPE. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3: 541-547.
35. SINGER, G. G. & A. K. ABBAS. 1994. The fas antigen is involved in peripheral but not thymic deletion of T cells in T cell receptor transgenic mice. Immunity 1: 365-371.
36. VAN PARIJS, L., A. IBRAGHIMOV & A. K. ABBAS. 1996. The roles of costimulation and fas in T cell apoptosis and peripheral tolerance. Immunity 4: 321-328.
37. LANE, P., C. HALLER & F. MCCONNELL. 1996. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects Vβ8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B. Eur. J. Immunol. 26: 858-862.
38. VYTH DREESE, F. A., T. A. DELLEMIJN, D. MAJOOR & D. DE JONG. 1995. Localization in situ of the co-stimulatory molecules B7.1, B7.2, CD40, and their ligands in normal human lymphoid tissue. Eur. J. Immunol. 25: 3023-3029.
39. JACOBSON, B. A., D. J. PANKA, K. NGUYEN, J. ERIKSON, A. K. ABBAS & A. MARSHAK-ROTHSTEIN. 1995. Anatomy of autoantibody production: dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity 3: 509-519.
40. SMITH, K. G., G. J. NOSSAL & D. M. TARLINTON. 1995. Fas is highly expressed in the germinal center, but is not required for regulation of the B-cell response to antigen. Proc. Natl. Acad. Sci. U.S.A. 92: 11628-11632.